These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 694485)

  • 1. [Platelet aggregation during various phases of the menstrual cycle and after therapy with ovulation inhibitors].
    Ohnhaus EE; Taras E
    Schweiz Med Wochenschr; 1978 Oct; 108(41):1580-1. PubMed ID: 694485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced platelet aggregation by oral contraceptives: effect of PG synthetase inhibitors.
    Sudhir S; Gupta LC; Singh J; Garg KN
    Indian J Physiol Pharmacol; 1982; 26(3):231-4. PubMed ID: 6816736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Modification of the thrombocyte function using hormonal contraception. 1. Thrombocyte count, thrombocyte propagation and platelet aggregation under hormonal contraception].
    Traub RF; Brandt M; Hofmann KD
    Zentralbl Gynakol; 1976; 98(3):161-5. PubMed ID: 61668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum prostaglandin F levels during menstrual cycle in women using oral contraceptives.
    Garg SK
    Int J Clin Pharmacol Ther Toxicol; 1983 Aug; 21(8):431-2. PubMed ID: 6629547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Methodological contribution to the controlled measurement of platelet aggregation].
    Ohnhaus EE; Beveridge T
    Schweiz Med Wochenschr; 1976 Oct; 106(40):1365-6. PubMed ID: 1006255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Modification of the thrombocyte function using hormonal contraception. 2. Platelet adhesiveness, thromboelastography, conclusions].
    Brandt M; Traub RF; Hofmann KD
    Zentralbl Gynakol; 1976; 98(3):166-74. PubMed ID: 61669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gas exchange and acid-base status during the normal human menstrual cycle and in subjects taking oral contraceptives [proceedings].
    Milne JA; Pack AI; Coutts JR
    J Endocrinol; 1977 Dec; 75(3):17P-18P. PubMed ID: 591821
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of oestrogen dose on whole blood platelet activation in women taking new low dose oral contraceptives.
    Norris LA; Bonnar J
    Thromb Haemost; 1994 Dec; 72(6):926-30. PubMed ID: 7740465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Central and peripheral actions of an oral contraceptive with reduced oestrogen content (author's transl)].
    Schneider WH; Schmid R; Spona J
    Wien Klin Wochenschr; 1977 Apr; 89(9):311-3. PubMed ID: 855349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Modification of cycle-dependent changes in the uterus by the intake of hormonal contraceptives].
    Bartl W; Nasr F; Bernaschek G
    Ultraschall Med; 1984 Apr; 5(2):74-6. PubMed ID: 6729435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Menstrual bleeding -- must that be? Extended use of oral hormonal contraceptives].
    Göretzlehner G
    Zentralbl Gynakol; 2005 Oct; 127(5):302-7. PubMed ID: 16195974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of the phase of the menstrual cycle and the birth control pill on athletic performance.
    Lebrun CM
    Clin Sports Med; 1994 Apr; 13(2):419-41. PubMed ID: 8013042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Menstrual patterns under hormonal contraception in adolescent girls and young women.
    Heinz M
    Pediatr Endocrinol Rev; 2006 Jan; 3 Suppl 1():146-9. PubMed ID: 16641849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Plasma concentrations of LH and of sex steroids during the normal menstrual cycle and during contraceptive treatment].
    Bayard F; Louvet JP; Moatti JP; Smilovici W; Duguet L; Boulard C
    J Gynecol Obstet Biol Reprod (Paris); 1975; 4(7):915-26. PubMed ID: 767402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The problem of modifying X-chromatin frequency using hormonal contraceptives].
    Meinhold P; Sommer K; Hoppe H; Klinger G
    Zentralbl Gynakol; 1975; 97(11):674-8. PubMed ID: 1189759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of oestro-progestogenic oral contraceptives on blood coagulation, fibrinolysis, and platelet aggregation.
    Ghezzo F; Mele A; Pegoraro L
    Haematologica; 1980 Dec; 65(6):737-45. PubMed ID: 6790364
    [No Abstract]   [Full Text] [Related]  

  • 17. Human cervical mucus. V. Oral contraceptives and mucus rheologic properties.
    Wolf DP; Blasco L; Khan MA; Litt M
    Fertil Steril; 1979 Aug; 32(2):166-9. PubMed ID: 38147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in coagulation factors and platelet function in response to progestational agents.
    McGrath KM; Castaldi PA
    Haemostasis; 1975; 4(2):65-72. PubMed ID: 1205337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Semiquantitative evaluation of isotope nephrograms in long-term continuous intake of contraceptive steroids].
    Voigt R; Klinger G; Stoll W
    Zentralbl Gynakol; 1976; 98(6):351-4. PubMed ID: 952139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fasting serum growth hormone levels and growth hormone responses to exercise during normal menstrual cycles and cycles of oral contraceptives.
    Hansen AP; Weeke J
    Scand J Clin Lab Invest; 1974 Nov; 34(3):199-205. PubMed ID: 4428162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.